Clearing Up Misperceptions About the Pain Standards

Published Online: Friday, November 1, 2013
Follow Pharmacy_Times:
In this podcast, Pat Adamski, director of the Joint Commission's Standards Interpretations Group, clears up common misperceptions about the organization's pain standards.

To listen to the podcast, click here.
Related Articles
It is compulsory for pharmacists to counsel all patients receiving opioids, evaluate the potential benefit of a naloxone reversal device, and contact the opioid prescriber if such a device is deemed appropriate.
Used alongside antidepressants, OTC analgesics and anti-inflammatories purchased from pharmacies may effectively treat patients with depression without increasing their risk of adverse events.
The transdermal buprenorphine manufacturer has launched an awareness campaign to address specific knowledge gaps among pharmacists that pertain to opioids.
Although pharmacies can legally dispense remaining refills of prescriptions for rescheduled hydrocodone combination products submitted prior to October 6, 2014, over the next 6 months, many drug chains have chosen not to honor those refills.
Latest Issues
$auto_registration$